Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-039979
Filing Date
2022-06-30
Accepted
2022-06-30 20:22:24
Documents
2
Period of Report
2022-06-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1535
2 POA DOCUMENT poa.txt EX-24 3423
  Complete submission text file 0001209191-22-039979.txt   6363
Mailing Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070 650-210-2900
ChemoCentryx, Inc. (Issuer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GENOCEA BIOSCIENCES, INC. 100 ACORN PARK DRIVE 5TH FLOOR CAMBRIDGE MA 02140
Business Address
Herron Jennifer Lyn (Reporting) CIK: 0001675774 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35420 | Film No.: 221059238